Repligen (RGEN) Tops Q2 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. LVS
7. SAP
8. CSX
9. LRCX
10. MRK

Go back to Repligen (RGEN) Tops Q2 EPS by 3c

Repligen Reports Second Quarter 2015 Financial Results

August 6, 2015 7:31 AM EDT

Product Sales Increase 38% to a Record $21.5 Million  Conference Call and Webcast Today at 8:30 a.m. ET 

WALTHAM, Mass., Aug. 06, 2015 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for the second quarter and six-month (year-to-date) periods ended June 30, 2015. Below are the Companys performance highlights, followed by updated financial guidance for the year 2015 and access information for todays webcast and conference call.

Second Quarter and Year-to-Date Financial Highlights 

... More